SOAT1
Sterol O-acyltransferase 1
As of the edition of 20 October 2026, SOAT1 (sterol O-acyltransferase 1, UniProt P35610) has 3 drugs tested at it and 3 companies on the list, 3 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P35610
- How well studied
- Chemical tools exist; no approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 5
- Disease areas
- Hormones; Heart and blood vessels; Nutrition and metabolism; Inherited and neonatal; Pregnancy and women's health; Urinary and reproductive; Cancer
- Registered trials of its drugs
- 8
Drugs at this target
| Status | Count |
|---|---|
| Stopped | 2 |
| Withdrawn from market | 1 |
| Total | 3 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Nevanimibe | Stopped | Phase 2 | none listed |
| Pactimibe | Stopped | Phase 3 | none listed |
| Benfluorex | Withdrawn from market | Phase 2 | none listed |
3 of 3 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 3 |
| Total on the list | 3 |
| Company | Route |
|---|---|
| Millendo Therapeutics | Route A |
| Millendo Therapeutics | Route A |
| Daiichi Sankyo | Route A |
The other 0 companies at SOAT1
In the product3 companies in all; 0 are not named here, and no score is.
See the 3 companies at SOAT1, ranked, with the facts behind eachRequest access. Nothing is shown until you do.